Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 36-44 , January 2010

Polymorphisms of β-adrenoceptor and Natriuretic Peptide Receptor Genes Influence the Susceptibility to and the Severity of Idiopathic Dilated Cardiomyopathy in a Chinese Cohort

  • Lingjie Wang, PhD, MD

      Affiliations

    • Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • ,
  • Lin Lu, PhD, MD

      Affiliations

    • Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • ,
  • Fengru Zhang, MD

      Affiliations

    • Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • ,
  • Qiujing Chen, MD

      Affiliations

    • Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • ,
  • Weifeng Shen, PhD, MD

      Affiliations

    • Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China
    • Corresponding Author InformationReprint requests: Wei Feng Shen, MD, PhD, Department of Cardiology, Rui Jin Hospital, 197 Rui Jin Road II, Shanghai 200025, P. R. China. Tel: +86-021-64370045-610910; Fax: +86-021-64457177.

Received 12 August 2008 ,Revised 2 July 2009 ,Accepted 3 August 2009.

References 

  1. Komajda M, Charron P, Tesson F. Genetic aspects of heart failure. Eur J Heart Fail. 1999;1:121–126
  2. Schonberger J, Seidman CE. Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet. 2001;69:249–260
  3. Poller W, Kuhl U, Tschoepe C, Pauschinger M, Fechner H, Schultheiss HP. Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med. 2005;83:579–586
  4. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667–1676
  5. Podlowski S, Wenzel K, Luther HP, Muller J, Bramlage P, Baumann G, et al. Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?. J Mol Med. 2000;78:87–93
  6. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994;33:9414–9419
  7. Green SA, Cole G, Jacinto M, Innis M, Liggett SB. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem. 1993;268:23116–23121
  8. Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Upregulation of beta (3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 2001;103:1649–1655
  9. Rathz DA, Brown KM, Kramer LA, Liggett SB. Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol. 2002;39:155–160
  10. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor. J Biol Chem. 1999;274:12670–12674
  11. Wei CM, Kim CH, Khraibi AA, Miller VM, Burnett JC. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro. Hypertension. 1994;23:903–907
  12. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke. 2004;35:814–818
  13. Rahmutula D, Nakayama T, Soma M, Kosuge K, Aoi N, Izumi Y, et al. Structure and polymorphisms of the human natriuretic peptide receptor C gene. Endocrine. 2002;17:85–90
  14. Rahmutula D, Nakayama T, Soma M, Sato M, Izumi Y, Kanmatsuse K, et al. Systematic screening of type B human natriuretic peptide receptor gene polymorphisms and association with essential hypertension. J Hum Hypertens. 2001;15:471–474
  15. Weber M, Burian M, Dragutinovic I, Moellmann H, Nef H, Elsaesser A, et al. Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system. Eur J Heart Fail. 2008;10:482–489
  16. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC, Maeda N. Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet. 2003;112:62–70
  17. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841–842
  18. DiBianco RA. large-scale trial of captopril for mild to moderate heart failure in the primary care setting. Clin Cardiol. 1991;14:676–682
  19. Torp-Pedersen CT, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, et al. [Dofetilide to patients with heart failure and left ventricular dysfunction]. Ugeskr Laeger. 2000;162:5948–5953
  20. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87:312–322
  21. Kaye DM, Smirk B, Williams C, Jennings G, Esler M, Holst D. Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics. 2003;13:379–382
  22. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–434
  23. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006;241:252–261
  24. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation. 2004;109:1640–1646
  25. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, et al. A C2077T polymorphism of the type B human natriuretic peptide receptor gene is not associated with myocardial infarction. Med Sci Monit. 2000;6:1056–1060
  26. Turki J, Lorenz JN, Green SA, Donnelly ET, Jacinto M, Liggett SB. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A. 1996;93:10483–10488
  27. Maqbool A, Hall AS, Ball SG, Balmforth AJ. Common polymorphisms of beta1-adrenoceptor: identification and rapid screening assay. Lancet. 1999;353:897
  28. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem. 2002;277:30429–30435
  29. Pierpont GL, Francis GS, DeMaster EG, Levine TB, Bolman RM, Cohn JN. Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy. Am J Cardiol. 1983;52:1033–1035
  30. Sole MJ, Liew CC. Catecholamines, calcium and cardiomyopathy. Am J Cardiol. 1988;62:20G–24G
  31. Lohmann FW. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers—a therapeutic approach?]. Herz. 1990;15:202–206
  32. Forleo C, Sorrentino S, Guida P, Romito R, De Tommasi E, Iacoviello M, et al. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy. J Cardiovasc Med (Hagerstown). 2007;8:589–595
  33. Forleo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V, et al. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy. Am J Med. 2004;117:451–458
  34. Ginsburg GS, Shah SH, McCarthy JJ. Taking cardiovascular genetic association studies to the next level. J Am Coll Cardiol. 2007;50:930–932

 The authors have no conflicts of interest.

PII: S1071-9164(09)00958-0

doi: 10.1016/j.cardfail.2009.08.003

Journal of Cardiac Failure
Volume 16, Issue 1 , Pages 36-44 , January 2010

Article Tools

* Image Usage & Resolution